Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.9.3921

Association between Ras association domain family 1A Promoter Methylation and Esophageal Squamous Cell Carcinoma: a Meta-analysis  

Yang, Jian-Zhou (School of Public Health, Central South University)
Ji, Ai-Fang (Central Laboratory, Heping Hospital Affiliated to Changzhi Medical College)
Wang, Jin-Sheng (Central Laboratory, Heping Hospital Affiliated to Changzhi Medical College)
Chen, Zhong-Yi (Central Laboratory, Heping Hospital Affiliated to Changzhi Medical College)
Wen, Shi Wu (School of Public Health, Central South University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.9, 2014 , pp. 3921-3925 More about this Journal
Abstract
RASSF1A has been reported to be a candidate tumor suppressor in esophageal squamous cell carcinoma (ESCC). However, the association between RASSF1A promoter methylation and ESCC remains unclear. Eligible studies were identified through searching PubMed, Medline, Web of Science, and the China National Knowledge Infrastucture database. Studies were pooled and odds ratios (ORs) with corresponding confidence intervals (CIs) were calculated. Funnel plots were also performed to evaluate publication bias. Twelve studies involving 859 cases and 675 controls were included in this meta-analysis. A significant association was observed between RASSF1A methylation and ESCC overall (OR = 11.7, 95% CI: 6.59-20.9, z=8.36, P<0.00001). Subgroup analysis showed that the OR for heterogeneous tissues was 5.35 (95% CI = 2.95-9.71) while for autologous tissues it was 16.0 (8.31-30.96). For patient sample size, the OR for the <50 subgroup was 9.92 (95% CI = 2.88-34.2) and for the 50 case group was 13.1 (95% CI = 6.59-25.91). The OR for a relationship between RASSF1A methylation and TNM stages was 0.27 (95% CI=0.10-0.77), whereas there were no significant differences in RASSF1A methylation in relation to gender and differentiation among ESCC cases. This meta-analysis suggests a significant association between RASSF1A methylation and ESCC.
Keywords
RAS associations domain family 1A; methylation; esophageal squamous cell carcinoma; meta-analysis;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 Zhang Y, Wang L, Wu H, et al (2007). Promoter methylation of RASSF1A gene in esophageal tissue. J Zhengzhou University (Medical Sciences), 42, 411-4.
2 Zhou SL, Cui J, Fan ZM, et al (2013). Polymorphism of A133S and promoter hypermethylation in Ras association domain family 1A gene (RASSF1A) is associated with risk of esophageal and gastric cardia cancers in Chinese population from high incidence area in northern China. BMC Cancer, 25, 259.
3 Qin Y, Wang L, Chang Z, et al (2009). RASSF1A methylation detection in esophageal cancer tissue and matched peripheral blood from the same patients. Chin J Cancer Prev Treat, 16, 359-61.
4 Ren T, Hu JM, Liu CX, et al (2009). Study on the correlation between methylation of RASSF1A gene in Hazakh's esophageal squamous cell carcinomas. J Nongken Medicine, 31, 481-6.
5 Su Y, Yin L, Liu R, et al (2014). Promoter methylation status of MGMT, hMSH2, and hMLH1 and its relationship to corresponding protein expression and TP53 mutations in human esophageal squamous cell carcinoma. Med Oncol, 31, 784.   DOI   ScienceOn
6 Teodoridis JM, Hall J, Marsh S, Kannall HD, Smyth C (2005). CpG islandmethylation of DNA damage response genes in advanced ovarian cancer. Cancer Res, 65, 8961-7.   DOI   ScienceOn
7 Vo LT, Thuan TB, Thu DM, et al (2013). Methylation profile of BRCA1, RASSF1A and ER in Vietnamese women with ovarian cancer. Asian Pac J Cancer Prev, 14, 7713-8.   과학기술학회마을   DOI   ScienceOn
8 Wang CC, Mao WM, Ling ZQ (2012). DNA methylation of E-cadherin and Ras association domain family 1A in peripheral blood and tumor tissue in patients with esophageal squamous cell carcinoma. Chin J Exp Surg, 29, 475-7.
9 Wong ML, Tao Q, Fu L, et al (2006). Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma. Int J Oncol, 28, 767-73.
10 Yamaguchi S, Kato H, Miyazaki T, et al (2005). RASSF1A gene promoter methylation in esophageal cancer specimens. Dis Esophagus, 18, 253-6.   DOI   ScienceOn
11 Li Y, Zhu CL, Nie CJ, et al (2013). Investigation of tumor suppressing function of CACNA2D3 in esophageal squamous cell carcinoma. PLoS One, 8, e60027.   DOI
12 Kuroki T, Trapasso F, Yendamuri S, et al (2003). Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma. Cancer Res, 63, 3724-8.
13 Lam KY (2000) Molecular biology of esophageal squamous cell carcinoma. Crti Rev Oncol Hematol, 33, 71-90.   DOI   ScienceOn
14 Li B, Wang B, Niu LJ, Jiang L, Qiu CC (2011). Hypermethylation of multiple tumor-related genes associated with DNMT3b up-regulation served as a biomarker for early diagnosis of esophageal squamous cell carcinoma. Epigenetics, 6, 307-16.   DOI
15 Pan QF, Li WT, Dong HC, et al (2013). PTEN hypermethylation profiles of Chinese Kazakh patients with esophageal squamous cell carcinoma. Dis Esophagus, doi: 10.1111/dote.12106.   DOI   ScienceOn
16 Liu WJ, Tan XH, Guo BP, et al (2013). Associations between RASSF1A promoter methylation and NSCLC: a meta-analysis of published data. Asian Pac J Cancer Prev, 14, 3719-24.   과학기술학회마을   DOI   ScienceOn
17 Ma J, Yu X, Guo L, Lu SH (2013). DUSP6, a tumor suppressor, is involved in differentiation and apoptosis in esophageal squamous cell carcinoma.Oncol Lett, 6, 1624-30.   DOI
18 Mao WM, Li P, Zheng QQ, et al (2011). Hypermethylation-modulated downregulation of RASSF1A expression is associated with the progression of esophageal cancer. Arch Med Res, 42, 182-8.   DOI   ScienceOn
19 Parkin DM, Bray F, Ferlay J, Pisani P (2001). Estimating the world cancer burden: Globocan 2000. Int J Cancer, 94, 153.6.   DOI   ScienceOn
20 Pfeifer GP, Dammann R (2005). Methylation of the Tumor Suppressor Gene RASSF1A in Human Tumors. Biochemistry (Moscow), 70, 576-83.   DOI
21 Egger M, Davey SG, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.   DOI   ScienceOn
22 Chen J, Huang ZJ, Duan YQ, Xiao XR, Jiang JQ, et al (2012). Aberrant DNA methylation of P16, MGMT, and hMLH1 genes in combination with MTHFR C677T genetic polymorphism and folate intake in esophageal squamous cell carcinoma. Asian Pac J Cancer Prev, 13, 5303-6.   과학기술학회마을   DOI   ScienceOn
23 Ge YZ, Xu LW, Jia RP, et al (2013). The association between RASSF1A promoter methylation and prostate cancer: evidence from 19 published studies. Tumour Biol. Doi 10.1007/s13277-013-1515-3.   DOI   ScienceOn
24 Cong DG, Wang SF (2007). Hypermethylation of promoter region of RAS association domain family gene1A in esophageal squamous cell carcinoma and significance thereof. Zhonghua Yi Xue Za Zhi, 87, 2932-4.
25 Ding S, Wu D, Zhou J, et al. (2007). Hypermthylation Status of RASSF1A Gene Promoter Region in Esophageal Squamous Cell Carcinoma. Chin J Min Inv Surg, 7, 1213-6.
26 Fiolka R, Zubor P, Janusicova V, et al (2013). Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer. Oncol Rep, 30, 2878-86.   DOI
27 He XY, Mao JS, Yi HX, Wu DL (2010). Relationship between RASSF1A expression and promoter methylation of RASSF1A gene in esophageal carcinoma. Modern Practical Medicine, 22, 1089-91.
28 Higgins JP, Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat Med, 21, 1539-58.   DOI   ScienceOn
29 Jemal A, Bray F, Center MM, et al. (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.   DOI
30 Jiang Y, Cui L, Chen WD, Shen SH, Ding LD (2012). The prognostic role of RASSF1A promoter methylation in breast cancer: a meta-analysis of published data. PLoS One, 7, e36780.   DOI
31 Agathanggelou A, Cooper WN, Latif F (2005). Role of the Ras-association domain family 1 tumor suppressor gene in human cancers. Cancer Res, 65, 3497-508.   DOI   ScienceOn
32 Taghavi N, Biramijamal F, Sotoudeh M, et al (2010). p16INK4a hypermethylation and p53, p16 and MDM2 protein expression in esophageal squamous cell carcinoma. BMC Cancer, 10, 138.   DOI   ScienceOn
33 Bondurant AE, Huang Z, Whitaker RS, Simel LR, Berchuck A (2011). Quantitative detection of RASSF1A DNA promoter methylation in tumors and serum of patients with serous epithelial ovarian cancer. Gynecol Oncol, 123, 581-7.   DOI   ScienceOn